These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9441068)

  • 21. [Floracide, a Russian 3rd generation fluoroquinolone in complex therapy of tuberculosis].
    Sokolova GB; Kirtaeva OV; Lazareva IaV; Tsybanev AA
    Antibiot Khimioter; 2008; 53(5-6):28-31. PubMed ID: 19069179
    [No Abstract]   [Full Text] [Related]  

  • 22. Emergence of extensive drug resistance during treatment for multidrug-resistant tuberculosis.
    Cox HS; Sibilia K; Feuerriegel S; Kalon S; Polonsky J; Khamraev AK; Rüsch-Gerdes S; Mills C; Niemann S
    N Engl J Med; 2008 Nov; 359(22):2398-400. PubMed ID: 19038891
    [No Abstract]   [Full Text] [Related]  

  • 23. Tuberculosis drug resistance comes full circle.
    Reichman LB
    Lancet; 2008 Mar; 371(9618):1052-3. PubMed ID: 18374825
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of tuberculosis--role of sparfloxacin?
    Bhatia RS; Sibia SS
    J Assoc Physicians India; 1999 Jul; 47(7):750. PubMed ID: 10778613
    [No Abstract]   [Full Text] [Related]  

  • 25. Mefloquine as a potential drug against multidrug-resistant tuberculosis.
    Krieger D; Vesenbeckh S; Schönfeld N; Bettermann G; Bauer TT; Rüssmann H; Mauch H
    Eur Respir J; 2015 Nov; 46(5):1503-5. PubMed ID: 26206875
    [No Abstract]   [Full Text] [Related]  

  • 26. Saving quinolones for tuberculosis.
    Bedi RS
    J Assoc Physicians India; 2003 Sep; 51():933-4. PubMed ID: 14710994
    [No Abstract]   [Full Text] [Related]  

  • 27. [Can ofloxacin constitute an alternative antitubercular treatment for BCG hepatitis?].
    Fendler JP; Debois H; Mége JL; Kepenekian G
    Prog Urol; 2002 Apr; 12(2):309-12. PubMed ID: 12108350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluoroquinolones and tuberculosis.
    Yew WW; Chau CH
    Int J Tuberc Lung Dis; 1998 Dec; 2(12):1050-2. PubMed ID: 9869128
    [No Abstract]   [Full Text] [Related]  

  • 29. [Analysis of causes of drug resistance and therapeutic effects on 27 multi-drug resistant pulmonary tuberculosis patients].
    Ye Z; Pei X; Yang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Aug; 20(4):234-6. PubMed ID: 10072811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ofloxacin in multidrug resistant tuberculosis.
    Walwaikar PP; Morye VK; Gawde AS
    J Indian Med Assoc; 2003 Mar; 101(3):210-2. PubMed ID: 14603981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The treatment of multidrug-resistant tuberculosis in Turkey.
    Tahaoğlu K; Törün T; Sevim T; Ataç G; Kir A; Karasulu L; Ozmen I; Kapakli N
    N Engl J Med; 2001 Jul; 345(3):170-4. PubMed ID: 11463011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug concentration in lung tissue in multidrug-resistant tuberculosis.
    Akkerman OW; van Altena R; Klinkenberg T; Brouwers AH; Bongaerts AH; van der Werf TS; Alffenaar JW
    Eur Respir J; 2013 Dec; 42(6):1750-2. PubMed ID: 24293422
    [No Abstract]   [Full Text] [Related]  

  • 33. Chemotherapy for tuberculosis. American Thoracic Society.
    Singh V
    Indian Pediatr; 1995 Aug; 32(8):943-4. PubMed ID: 8635851
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug resistant tuberculosis.
    Singh M; Jayanthi S; Kumar L
    Indian J Pediatr; 2000 Feb; 67(2 Suppl):S41-6. PubMed ID: 11129907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suboptimal moxifloxacin and levofloxacin drug exposure during treatment of patients with multidrug-resistant tuberculosis: results from a prospective study in China.
    Davies Forsman L; Niward K; Kuhlin J; Zheng X; Zheng R; Ke R; Hong C; Werngren J; Paues J; Simonsson USH; Eliasson E; Hoffner S; Xu B; Alffenaar JW; Schön T; Hu Y; Bruchfeld J
    Eur Respir J; 2021 Mar; 57(3):. PubMed ID: 33154028
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term treatment of pulmonary tuberculosis with ofloxacin in a subject with liver cirrhosis.
    Bagnato GF; Di Cesare E; Gulli S; Cucinotta D
    Monaldi Arch Chest Dis; 1995 Aug; 50(4):279-81. PubMed ID: 7550207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Levofloxacin (Tavanic) in the treatment of corneal ulcers].
    Maĭchuk IuF
    Antibiot Khimioter; 2003; 48(6):16-9. PubMed ID: 14558414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Maxaquin in the combined treatment of tuberculosis].
    Sokolova GB; Mozhokina GN; Kunichan AD; Elistratova NA; Perel'man MI
    Probl Tuberk; 2000; (5):35-9. PubMed ID: 11077850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effectiveness of maxaquin and tarivid in combined therapy of patients with chronic sinusitis].
    El'kun GB
    Vestn Otorinolaringol; 1999; (6):45-6. PubMed ID: 10596605
    [No Abstract]   [Full Text] [Related]  

  • 40. Increased resistance to ciprofloxacin and ofloxacin in multidrug-resistant mycobacterium tuberculosis isolates from patients seen at a tertiary hospital in the Philippines.
    Grimaldo ER; Tupasi TE; Rivera AB; Quelapio MI; Cardaño RC; Derilo JO; Belen VA
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):546-50. PubMed ID: 11409582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.